ImmunityBio
IBRX
#3744
Rank
โ‚น206.45 B
Marketcap
โ‚น241.91
Share price
-4.71%
Change (1 day)
-48.44%
Change (1 year)

Revenue for ImmunityBio (IBRX)

Revenue in 2024 (TTM): โ‚น1.24 Billion

According to ImmunityBio's latest financial reports the company's current revenue (TTM ) is โ‚น1.26 Billion. an increase over the revenue in the year 2023 that were of โ‚น51.78 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunityBio from 2020 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น1.26 B2342.84%
2023 โ‚น51.78 M160.73%
2022 โ‚น19.86 M-71.43%
2021 โ‚น69.51 M57.12%
2020 โ‚น44.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA